Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer.

Journal of cancer research and clinical oncology - 1 Nov 2015

Muendlein Axel, Rohde Bettina H, Gasser Klaus, Haid Anton, Rauch Stephanie, Kinz Elena, Drexel Heinz, Hofmann Wera, Schindler Verena, Kapoor Rita, Decker Thomas, Lang Alois H

Abstract excerpt

PURPOSE: Testing for BRCA1 and BRCA2 mutations in breast cancer patients is used to identify the risk of second primary cancers and the risk of cancer in the patients' family. Women with triple-negative breast cancer (TNBC) are thought to be more likely to be BRCA1/2 mutation carriers, but most national guidelines for genetic testing, including those used in Germany and Austria, do not consider receptor triple...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Austria

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA1 Protein

Share to BRCA2 Protein

Share to Family

Share to Germany

Share to Neoplasms, Second Primary

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 25971625
DOI: 10.1007/s00432-015-1986-2

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer.PMID 25971625Read ↗

Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer.Semantic proximity Read ↗

Germline Mutations in Triple-Negative Breast CancerSemantic proximity Read ↗

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.Semantic proximity Read ↗

BRCA1/2 mutations and triple negative breast cancers.Semantic proximity Read ↗

A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients.Semantic proximity Read ↗

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer historySemantic proximity Read ↗

Clinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer.Semantic proximity Read ↗

Therapeutic landscape in mutational triple negative breast cancerSemantic proximity Read ↗

BRCA1 and BRCA2 mutations and their clinical relevance in selected women diagnosed with triple-negative breast cancer in Kenya: a descriptive cross-sectional study.Semantic proximity Read ↗

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.Semantic proximity Read ↗

Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis.Semantic proximity Read ↗

Prevalence of <i>BRCA</i> mutations in an unselected population of triple‐negative breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.